These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 19040997)
21. Effect of secondary hyperparathyroidism on the anaemia of end-stage renal failure: in vivo and in vitro studies. Grützmacher P; Radtke HW; Fassbinder W; Koch KM; Schoeppe W Proc Eur Dial Transplant Assoc; 1983; 20():739-45. PubMed ID: 6657694 [TBL] [Abstract][Full Text] [Related]
22. r.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline. Tapolyai M; Kadomatsu S; Perera-Chong M BMC Nephrol; 2003 Jun; 4():3. PubMed ID: 12809563 [TBL] [Abstract][Full Text] [Related]
23. Appropriate hematocrit levels of erythropoietin supplementary therapy in end-stage renal failure complicated by coronary artery disease. Nagao K; Tsuchihashi K; Ura N; Nakata T; Shimamoto K Can J Cardiol; 1997 Aug; 13(8):747-53. PubMed ID: 9284841 [TBL] [Abstract][Full Text] [Related]
24. Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism. Esposito MG; Cesare CM; De Santo RM; Cice G; Perna AF; Violetti E; Conzo G; Bilancio G; Celsi S; Annunziata F; Iannelli S; De Santo NG; Cirillo M; Livrea A J Nephrol; 2008; 21 Suppl 13():S92-6. PubMed ID: 18446739 [TBL] [Abstract][Full Text] [Related]
25. Clinical and operative management of persistent hyperparathyroidism after renal transplantation: a single-center experience. Gilat H; Feinmesser R; Vinkler Y; Morgenstern S; Shvero J; Bachar G; Shpitzer T Head Neck; 2007 Nov; 29(11):996-1001. PubMed ID: 17427968 [TBL] [Abstract][Full Text] [Related]
26. Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease. Artunc F; Risler T Nephrol Dial Transplant; 2007 Oct; 22(10):2900-8. PubMed ID: 17556407 [TBL] [Abstract][Full Text] [Related]
27. Surgical findings and post-operative parathormone levels in patients with secondary hyperparathyroidism. Verdonck J; Geuens G; Delaere P; Vander Poorten V; Evenepoel P; Debruyne E B-ENT; 2009; 5(3):143-8. PubMed ID: 19902849 [TBL] [Abstract][Full Text] [Related]
28. Beneficial hematologic effects of daily oral ascorbic acid therapy in ESRD patients with anemia and abnormal iron homeostasis: a preliminary study. Sirover WD; Siddiqui AA; Benz RL Ren Fail; 2008; 30(9):884-9. PubMed ID: 18925528 [TBL] [Abstract][Full Text] [Related]
29. Effect of parathyroidectomy on anemia in chronic renal failure. Barbour GL Arch Intern Med; 1979 Aug; 139(8):889-91. PubMed ID: 464702 [TBL] [Abstract][Full Text] [Related]
30. Calcium requirements after parathyroidectomy in patients with refractory secondary hyperparathyroidism. Viaene L; Evenepoel P; Bammens B; Claes K; Kuypers D; Vanrenterghem Y Nephron Clin Pract; 2008; 110(2):c80-5. PubMed ID: 18758187 [TBL] [Abstract][Full Text] [Related]
31. Role of parathyroidectomy on anemia control and erythropoiesis-stimulating agent need in secondary hyperparathyroidism of chronic kidney disease. A retrospective study in 30 hemodialysis patients. Conzo G; Perna A; Della Pietra C; Esposito D; Nunziata A; Palazzo A; Pizza A; Satta E; Sciascia V; Santini L Ann Ital Chir; 2013; 84(1):25-31. PubMed ID: 23047642 [TBL] [Abstract][Full Text] [Related]
32. Total parathyroidectomy without autotransplantation in dialysis patients and renal transplant recipients, long-term follow-up evaluation. Drakopoulos S; Koukoulaki M; Apostolou T; Pistolas D; Balaska K; Gavriil S; Hadjiconstantinou V Am J Surg; 2009 Aug; 198(2):178-83. PubMed ID: 19217601 [TBL] [Abstract][Full Text] [Related]
33. Parathyroidectomy followed by kidney transplantation can improve bone mineral density in patients with secondary hyperparathyroidism. Chou FF; Hsieh KC; Chen YT; Lee CT Transplantation; 2008 Aug; 86(4):554-7. PubMed ID: 18724225 [TBL] [Abstract][Full Text] [Related]
34. [The effect of subtotal parathyroidectomy in patients on haemodialysis]. Vujić D; Majster Z; Lazić N; Radmirović A; Kekić Z Srp Arh Celok Lek; 1994; 122(1-2):34-7. PubMed ID: 17972801 [TBL] [Abstract][Full Text] [Related]
35. Optimizing anemia management in hospitalized patients with end-stage renal disease. Heung M; Mueller BA; Segal JH Ann Pharmacother; 2009 Feb; 43(2):276-82. PubMed ID: 19141655 [TBL] [Abstract][Full Text] [Related]
36. Anemia and secondary hyperparathyroidism. Zingraff J; Drüeke T; Marie P; Man NK; Jungers P; Bordier P Arch Intern Med; 1978 Nov; 138(11):1650-2. PubMed ID: 718313 [TBL] [Abstract][Full Text] [Related]
37. Role of erythropoietin in anemia after heart transplantation. Gleissner CA; Klingenberg R; Staritz P; Koch A; Ehlermann P; Wiggenhauser A; Dengler TJ Int J Cardiol; 2006 Oct; 112(3):341-7. PubMed ID: 16309765 [TBL] [Abstract][Full Text] [Related]
38. Long-term results of subtotal vs total parathyroidectomy without autotransplantation in kidney transplant recipients. Rayes N; Seehofer D; Schindler R; Reinke P; Kahl A; Ulrich F; Neuhaus P; Nüssler NC Arch Surg; 2008 Aug; 143(8):756-61; discussion 761. PubMed ID: 18711035 [TBL] [Abstract][Full Text] [Related]
39. Clinical epidemiology of parathyroidectomy in hemodialysis patients: the USRDS waves 1, 3, and 4 study. Slinin Y; Foley RN; Collins AJ Hemodial Int; 2007 Jan; 11(1):62-71. PubMed ID: 17257358 [TBL] [Abstract][Full Text] [Related]
40. Sleep disturbances before and after parathyroidectomy for secondary hyperparathyroidism. Chou FF; Lee CH; Chen JB; Huang SC; Lee CT Surgery; 2005 Apr; 137(4):426-30. PubMed ID: 15800490 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]